-
October 12, 2012
Isis Pharmaceuticals, Inc. (ISIS) recently announced that it has invested $3 million in biopharma company Regulus ...
-
October 10, 2012
PDL BioPharma, Inc. (PDLI) and AxoGen, Inc. (AXGN) recently completed a structured financing transaction. As per the ...
-
October 09, 2012
Pasadena, California-based real estate investment trust (REIT), Alexandria Real Estate Equities, Inc. (ARE), ...
-
October 05, 2012
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, Inc. (ISIS), recently ...
-
September 27, 2012
Biogen Idec (BIIB) and partner, Swedish Orphan Biovitrum, recently presented positive phase III top-line results on ...
-
September 24, 2012
Positive earnings estimate revisions, a strong second quarter and an upbeat guidance for 2012 helped Biogen Idec, ...
-
September 18, 2012
We are moving back to a Neutral recommendation on Alkermes plc (ALKS) as we believe the stock is fairly valued at ...
-
September 14, 2012
Biogen Idec (BIIB) recently announced that it has sold its royalty and other rights related to GlaxoSmithKline's ...
-
September 13, 2012
Sanofi (SNY) and its subsidiary Genzyme recently announced that their oral candidate for relapsing forms of multiple ...
-
September 07, 2012
PDL BioPharma Inc. (PDLI) recently announced that it expects to generate third quarter 2012 royalty revenues of $85 ...
-
September 06, 2012
Alnylam Pharmaceuticals, Inc. (ALNY) recently presented complete results from a phase IIb trial on ALN-RSV01 at the ...
-
September 06, 2012
Elan Corporation (ELN) recently initiated a phase II placebo-controlled, safety and efficacy study with oral ...
-
September 06, 2012
The morning has been good for the market. The Nasdaq has risen 1.9%; the S&P 500 is up 1.8%; and the Dow has moved ...
-
August 29, 2012
Alnylam Pharmaceuticals, Inc. (ALNY) and Monsanto Company (MON) recently formed a strategic alliance to implement ...
-
August 28, 2012
Sanofi's (SNY) subsidiary, Genzyme, recently announced that the US Food and Drug Administration (FDA) has issued a ...
-
August 22, 2012
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, Inc. (ISIS), recently ...
-
August 20, 2012
Teva Pharmaceutical Industries Ltd.'s (TEVA) subsidiary, Teva Women's Health, Inc., recently announced the ...
-
August 16, 2012
Regulus Therapeutics Inc. and Biogen Idec (BIIB) recently entered into a deal to identify microRNAs ...
-
August 14, 2012
Acorda Therapeutics Inc. (ACOR) recently announced results from a post-marketing commitment study evaluating a 5 mg ...
-
August 14, 2012
Elan Corporation (ELN) recently announced its decision to split into two separate publicly traded companies. The ...
